| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | FILTRO MEDICAL INC | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 000 | 1 | NIH | 1/29/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,000,000 ) |
| | 2024 | 2024 | FILTRO MEDICAL INC | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 000 | 3 | NIH | 8/5/2024 | $1,000,000 |
|
| Issue Date FY: 2023 ( Subtotal = $1,000,000 ) |
| | 2023 | 2023 | FILTRO MEDICAL INC. | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 000 | 2 | NIH | 9/18/2023 | $1,000,000 |
| | 2023 | 2023 | FILTRO MEDICAL INC. | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 001 | 2 | NIH | 9/25/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $199,664 ) |
| | 2022 | 2022 | FILTRO MEDICAL INC. | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 000 | 1 | NIH | 6/17/2022 | $199,664 |
|
| Issue Date FY: 2021 ( Subtotal = $400,000 ) |
| | 2021 | 2021 | FILTRO MEDICAL INC. | 1123 CARNFORTH CT | SAN JOSE | CA | 95120-4212 | SANTA CLARA | USA | R42CA265316 | Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy | 000 | 1 | NIH | 9/23/2021 | $400,000 |
|
|
